Literature DB >> 8950361

Free to total prostate-specific antigen (PSA) ratio is superior to total-PSA in differentiating benign prostate hypertrophy from prostate cancer.

P J Van Cangh1, P De Nayer, P Sauvage, B Tombal, M Elsen, F Lorge, R Opsomer, F X Wese.   

Abstract

BACKGROUND: Serum prostate-specific antigen (PSA) exists in different molecular forms, and their respective concentration has been proposed as a useful tool to improve discrimination between benign prostatic hypertrophy (BPH) and prostate cancer (PC).
METHODS: The relevance of the free to total PSA ratio was prospectively studied in a selected urology clinic population of 420 patients. Total serum PSA ranged from 2.1 to 30 ng/ml; 154 had PC and 266 had BPH.
RESULTS: Receiver operating characteristic (ROC) curves were constructed for the total population (total-PSA range from 2.1 to 30 ng/ml) and for the diagnostic gray zone of 2.1-10 ng/ml. For the two groups, the free to total PSA ratio had a higher specificity than total-PSA for all sensitivity levels. Cut-off values were found to, vary with prostate weight.
CONCLUSIONS: Although free to total PSA ratio demonstrated better performances than total-PSA, its use in screening appears problematic, due to the low prevalence of prostate cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8950361

Source DB:  PubMed          Journal:  Prostate Suppl        ISSN: 1050-5881


  6 in total

1.  Advantages of replacing the total PSA assay with the assay for PSA-alpha 1-antichymotrypsin complex for the screening and management of prostate cancer.

Authors:  J T Wu; G H Liu
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

2.  Using the free-to-total prostate-specific antigen ratio to detect prostate cancer in men with nonspecific elevations of prostate-specific antigen levels.

Authors:  R M Hoffman; D L Clanon; B Littenberg; J J Frank; J C Peirce
Journal:  J Gen Intern Med       Date:  2000-10       Impact factor: 5.128

3.  Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention.

Authors:  Dean Ornish; Mark Jesus M Magbanua; Gerdi Weidner; Vivian Weinberg; Colleen Kemp; Christopher Green; Michael D Mattie; Ruth Marlin; Jeff Simko; Katsuto Shinohara; Christopher M Haqq; Peter R Carroll
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-16       Impact factor: 11.205

4.  The value of screening tests for detection of prostate cancer in 1000 saudi men.

Authors:  Baher A Kamal
Journal:  J Family Community Med       Date:  2004-09

5.  Soft covering based rough sets and their application.

Authors:  Şaziye Yüksel; Zehra Güzel Ergül; Naime Tozlu
Journal:  ScientificWorldJournal       Date:  2014-09-09

Review 6.  The role of free prostate-specific antigen in prostate cancer detection.

Authors:  M Han; S R Potter; A W Partin
Journal:  Curr Urol Rep       Date:  2000-05       Impact factor: 2.862

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.